Stay updated on Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Sign up to get notified when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.

Latest updates to the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the site revision history.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now includes a new Revision: v3.4.2, and existing notices about government funding and operating status (v3.4.1) have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check66 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page version to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check73 days agoChange DetectedGlossary visibility was added and a new 'Last Update Submitted that Met QC Criteria' field appears, with the revision label 'v3.4.0'. The previous label 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were replaced by capitalized equivalents ('No FEAR Act Data'), and the revision/version reference updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check87 days agoChange DetectedThe page shows a backend/frontend revision update: Revision: v3.3.4 was added and Revision: v3.3.3 was removed, with no changes to the study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.